The FDA has approved the first-ever gene editing therapy we talked about in episode 106 that treats sickle cell disease which affects over 100,000 mostly Black Americans in the United States.

Rumor has it that Apple’s iMessage will not be classified as a gatekeeper service under the EU’s Digital Markets Act and will not have to become interoperable with other messaging services.

Genetic Testing company 23andMe got hacked, lost 6.9 million users' data, and changed its TOS to avoid getting sued.

And the usual suspects slow down government-backed EV charging infrastructure here in the U.S.

Link to Show Notes

Hosted on Acast. See acast.com/privacy for more information.